Genitourinary and Renal Cell Carcinoma
Arcus Biosciences Inc. funds clinical research in advanced clear cell renal cell carcinoma, metastatic clear cell renal cell carcinoma, and broader renal cell carcinoma settings, with interest in treatment combinations for difficult-to-treat disease.
- Advanced clear cell renal cell carcinoma
- Metastatic clear cell renal cell carcinoma
- Renal cell carcinoma
- Solid tumors
Its portfolio also includes studies in advanced solid tumor populations where renal cancer remains a major therapeutic focus.
Non-Small Cell Lung Cancer and Lung Cancer
The sponsor supports research across non-small cell lung cancer, including non squamous and squamous subtypes, as well as broader lung cancer indications.
- Non-small cell lung cancer
- Non squamous non-small cell lung cancer
- Squamous non-small cell lung cancer
- Lung cancer
These studies reflect a strong interest in immunotherapy-based and combination approaches for advanced thoracic malignancies.
Gastrointestinal Cancers
Arcus Biosciences Inc. is active in multiple gastrointestinal malignancies, including gastric cancer, esophageal cancer, gastroesophageal junction adenocarcinoma, and other upper gastrointestinal tract malignancies.
- Gastric cancer
- Esophageal cancer
- Gastroesophageal junction adenocarcinoma
- Upper gastrointestinal tract cancer
Research also extends to metastatic esophageal or gastric cancer, advanced upper gastrointestinal tract malignancies, and broader gastrointestinal tract malignancies.
Pancreatic and Colorectal Cancer
The sponsor funds studies in pancreatic ductal adenocarcinoma, metastatic pancreatic ductal adenocarcinoma, pancreatic cancer, and metastatic colorectal cancer, covering aggressive gastrointestinal disease settings.
- Pancreatic ductal adenocarcinoma
- Metastatic pancreatic ductal adenocarcinoma
- Pancreatic cancer
- Metastatic colorectal cancer
Additional activity includes gastrointestinal cancer and advanced upper gastrointestinal tract malignancies with interest in combination therapy development.
Hematologic Malignancies and Other Solid Tumors
Arcus Biosciences Inc. also supports research in hematologic cancer, including diffuse large B-cell lymphoma, non-Hodgkin lymphoma, and multiple myeloma, alongside studies in melanoma, cervical cancer, and other advanced malignancies.
- Diffuse large B-cell lymphoma
- Non-Hodgkin lymphoma
- Multiple myeloma
- Melanoma
Its research landscape includes gynecological cancer, solid tumors, and broader advanced malignancy programs.
